SCHEMBL5049567

SCHEMBL5049567

Clc1ccc(-c2c(-c3ccccc3)nnn2Cc2ccccc2)cc1

nearest known ligand 0.71

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CDC7 O00311 7/20 0.60
MAP4K4 O95819 5/20 0.60
PRKACA P17612 5/20 0.60
CDK2 P24941 5/20 0.60
GSK3B P49841 5/20 0.60
CLK4 Q9HAZ1 3/20 0.60
MKNK2 Q9HBH9 3/20 0.60
PIM1 P11309 3/20 0.60
HIPK2 Q9H2X6 3/20 0.60
ROCK2 O75116 4/20 0.57
DAPK3 O43293 3/20 0.57
PRKD3 O94806 3/20 0.57
FLT3 P36888 3/20 0.57
CLK2 P49760 3/20 0.57
PRKX P51817 3/20 0.57
JAK3 P52333 3/20 0.57
CDK5 Q00535 3/20 0.57
MAP4K2 Q12851 3/20 0.57
CAMK2D Q13557 3/20 0.57
DYRK1A Q13627 3/20 0.57

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5051897 1.00 CDC7 (0.60) CDC7MAP4K4PRKACACDK2GSK3B
SCHEMBL2898117 0.92 IDO1 (0.65) CDC7MAP4K4PRKACACDK2GSK3B
SCHEMBL5051921 0.90 TDO2 (0.54) CDC7MAP4K4PRKACACDK2GSK3B
SCHEMBL5050336 0.90 TDO2 (0.54) CDC7MAP4K4PRKACACDK2GSK3B
SCHEMBL5047920 0.79 SLC9A1 (0.49) CYP19A1MEN1KMT2ACYP1A2CYP2C9
SCHEMBL5053635 0.79 SLC9A1 (0.49) CYP19A1MEN1KMT2ACYP1A2CYP2C9
SCHEMBL5049432 0.78 SLC9A1 (0.50) MEN1KMT2ACYP1A2CYP2C9CYP2C19
SCHEMBL5049522 0.78 SLC9A1 (0.50) MEN1KMT2ACYP1A2CYP2C9CYP2C19
SCHEMBL3637386 0.77 CDC7 (0.55) CDC7MAP4K4PRKACACDK2GSK3B
SCHEMBL28340574 0.75 CDC7 (0.64) CDC7MAP4K4PRKACACDK2GSK3B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1921072-A1 1,2,3-Triazole derivatives as cannabinoid-receptor modulators Laboratorios del Dr. Esteve S.A. (ES) 2008-05-14 EP claimed
EP-1921072-A1 1,2,3-Triazole derivatives as cannabinoid-receptor modulators Laboratorios del Dr. Esteve S.A. (ES) 2008-05-14 EP disclosed